NHS GP Highlights ‘Massively Underdiagnosed’ Condition Causing Breathlessness and Pain
In a recent social media post, NHS GP Dr Ahmed, also known as @Dra_says, has drawn attention to a ‘massively underdiagnosed’ condition that can lead to various common symptoms such as breathlessness, itching, and pain. Mast Cell Activation Syndrome (MCAS) was the focus of Dr Ahmed’s TikTok video, shedding light on a condition that NHS research indicates can trigger severe allergic symptoms ranging from itching and swelling to potentially fatal anaphylactic reactions. If someone suspects a severe allergic reaction, especially if they are experiencing trouble breathing, it is essential to call 999 immediately.
Diagnosing MCAS can be challenging, as explained by Dr Ahmed, who believes the condition is significantly underdiagnosed. Mast cells, present throughout the body in the skin, gut, and respiratory system, play a crucial role in the immune system by detecting allergens and releasing histamine to produce symptoms. However, in MCAS, these cells can be triggered by factors that typically wouldn’t cause a reaction, such as food, heat, cold, or stress, leading to a wide range of symptoms.
Symptoms of MCAS can vary widely, making diagnosis difficult. Dr Ahmed highlighted skin writing as a notable symptom, where minor touch to the skin can cause a raised red reaction. Although diagnosing MCAS can be challenging due to normal or borderline test results, specialist tests and criteria can aid in diagnosis, despite not being fully available on the NHS yet. Treatment for MCAS involves avoiding triggers and using H1 and H2 receptor antagonists, which have shown transformative effects for some patients, improving conditions such as fibromyalgia.
While many symptoms may be linked to MCAS, consulting a doctor is necessary if symptoms persist and worsen. The UK Mastocytosis Support Group emphasizes the lack of recognition for conditions like MCAS within the UK medical system, despite international acknowledgment in countries like America. As awareness and understanding of MCAS grow, patients may receive better support and treatment options.